Article ID Journal Published Year Pages File Type
8228722 International Journal of Radiation Oncology*Biology*Physics 2011 6 Pages PDF
Abstract
The low toxicity of trastuzumab concurrently with WBRT should probably not justify delays. Although promising, these preliminary data warrant additional validation of trastuzumab as a potential radiosensitizer for WBRT in brain metastases from breast cancer in the setting of a clinical trial.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Preliminary Results of Whole Brain Radiotherapy With Concurrent Trastuzumab for Treatment of Brain Metastases in Breast Cancer Patients
Authors
, , , , , , , , , ,